Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and raise healthcare costs for patients, some drug trade groups warn. They also ...